Reuters examines how the fight against malaria in Africa is helping to fuel the continent’s economic growth. “The number of malaria deaths has fallen dramatically in the last decade due to increased aid spending on basic items such as insecticide-treated bed nets and drugs, the World Health Organization (WHO) says,” the news agency writes, noting that an experimental vaccine from GlaxoSmithKline is showing prospect. The news agency discusses the efforts of AngloGold Ashanti, the world’s third largest gold producer, to prevent and treat malaria among its workers, which “‘made economic sense because of the absenteeism and the cost of medication,’ said Steve Knowles, the head of AngloGold’s anti-malaria operations.”
“International health experts say the global campaign to eradicate polio has reached a critical stage, with Afghanistan, Pakistan and Nigeria the only countries where the crippling and potentially deadly virus is still prevalent,” VOA News reports. “Health officials in Pakistan say they are redoubling efforts to vaccinate every child against polio after 198 new cases were reported in the country last year, the largest number anywhere in the world,” the news service notes. It goes on to highlight several challenges to the efforts, including “an ongoing insurgency and the influx of millions of Pakistani and Afghan refugees” and public opposition to the vaccinations resulting from misperceptions and concerns about safety (Padden, 6/9).
Opinion Pieces Published In Advance Of 'Child Survival Call To Action' Event To Take Place In Washington
The following are summaries of several opinion pieces published in anticipation of the Child Survival Call to Action event to be held on June 14-15 in Washington, D.C. Convened by the governments of the United States, Ethiopia and India, and organized in close collaboration with UNICEF, the event will focus on ending preventable child death through the survival of newborns, children and mothers and will convene 700 prominent leaders from government, the private sector, faith-based organizations and civil society to kick off a long-term, focused effort to save children’s lives.
AllAfrica.com/Guardian examine efforts to prevent and treat cervical cancer among women in Kenya, where an estimated 3,400 women die of the disease each year and only five percent receive screening. “Kenya’s national reproductive health strategic plan has addressed cervical cancer largely through the roll-out of a low-cost screening tool known as VIA (visual inspection of the cervix using ascetic acid),” but experts agree that more widespread use of cervical cancer vaccines and public education campaigns about the disease would be more effective at preventing and catching cases earlier, the news service reports. “Once the public owns this problem and pushes for it, … then the government would be forced to implement [a vaccine] strategy in full,” Lucy Muchiri, a pathologist specializing in cervical cancer at Kenyatta National Hospital and the University of Nairobi, said, the news service notes (Njoroge, 6/12).
“Brazilian researchers say they have successfully tested a vaccine against schistosomiasis, a disease caused by parasitic worms that afflicts more than 200 million people worldwide,” Agence France-Presse reports. Researchers from the Oswaldo Cruz Institute in Rio de Janeiro “said it had successfully tested the vaccine in humans, but that more testing would be required in areas where the parasite is most common, mainly in Africa and South America,” the news agency writes. Institute researcher Tania Araujo-Jorge said she hopes the vaccine will be available for distribution within three years, according to AFP (6/13).
“Impressed with India’s successful effort in polio eradication,” a nine-member Pakistani delegation on Thursday met India’s health minister Ghulam Nabi Azad and senior officials of the Ministry to discuss the country’s polio eradication program, the Press Trust of India/Business Standard reports, noting that India achieved a polio-free status as of January (5/31). “‘The focus of our visit here was for us to learn firsthand from the government officials and partners exactly what it took for India to become polio free,’ leader of the Pakistan delegation, Shahnaz Wazir Ali, said,” the PTI/Times of India writes (5/31).
“Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million doses packaged in 10-dose vials,” a Sabin Vaccine Institute press release reports. The study, published in the July 6 issue of the journal Vaccine, “used data on a vaccine developed by U.S. NIH and the facilities of the Instituto Butantan in Sao Paulo, Brazil,” the press release notes, adding the findings “should provide confidence to ministries of health that they can aggressively plan for the inclusion of dengue vaccine in their immunization programs, as the vaccine should be available at a cost that even middle-income and developing countries can afford” (6/27).
Gates Foundation Plans To Invest In Biotech Companies To Improve Global Access To Treatments, Vaccines For Infectious Diseases
The Bill & Melinda Gates Foundation “plans to take equity stakes in up to a dozen biotech companies this year, signaling a shift towards a ‘venture capital’ approach at the world’s biggest philanthropic organization” and “mark[ing] a further move away from its traditional approach of grant-giving and towards a more business-oriented way to support the development of treatments and vaccines for infectious diseases affecting the world’s poor,” the Financial Times reports. Trevor Mundel, president of the Gates Foundation’s Global Health Program, said the foundation will make a series of investments worth several million dollars each “and not ask for a return but for global access. … We will specify the countries and the diseases,” according to the newspaper. The Financial Times notes that “[t]he move points to growing interest in working directly with companies rather than primarily through co-operating via non-profit ‘product development partnerships’ or intermediaries such as the Medicines for Malaria Venture and the Tuberculosis Alliance” (Jack, 6/26).
“Zimbabwe embarked on a massive immunization campaign against measles and polio on Monday, targeting about two million children under the age of five,” VOA News reports. “Health and Child Welfare Minister Henry Madzorera launched the program in Harare, administering vaccines to a number of children and doses of vitamin A supplements,” the news service writes, noting, “Statistics show that at least 100 children die of largely preventable diseases in the country every day, and officials say the week-long vaccination program is meant to roll back the worrying mortality rate.”
Noting that polio is endemic in only Afghanistan, Pakistan, and Nigeria, and the WHO recently declared the disease a “programmatic emergency” to “galvanize work” in those three countries, a Washington Post editorial states, “A renewed campaign [against the disease] will be costly.” The editorial notes, “The Global Polio Eradication Initiative, set up in 1988 by the WHO, UNICEF, the Centers for Disease Control and Prevention (CDC) and Rotary International, says that it needs an additional $945 million for a total budget of $2.19 billion this year and next.”